ABI
PFE icon

Adamant Biomedical Investments’s Pfizer PFE Stock Holding History

Adamant Biomedical Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$1.87M Hold
63,240
– – 0.45% 67
2014
Q3 		$1.77M Buy
+63,240
New +$1.77M 0.44% 64

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Adamant Biomedical Investments's PFE Position: Q4 2014 in Review

Adamant Biomedical Investments held its Pfizer (PFE) position steady in Q4 2014 at 63,240 shares worth $1.87M. The position accounts for 0.45% of the portfolio, ranked #67.

Adamant Biomedical Investments first reported a position in PFE in Q3 2014 and has held it in 2 quarters since. 1,860 funds tracked by Wall St. Rank hold PFE as of Q4 2014.

  • Adamant Biomedical Investments held 63,240 shares of Pfizer worth $1.87M as of Q4 2014.
  • Adamant Biomedical Investments left its Pfizer share count unchanged in Q4 2014.
  • Pfizer made up 0.45% of Adamant Biomedical Investments's portfolio in Q4 2014, its #67 holding.
  • Adamant Biomedical Investments first reported a position in Pfizer in Q3 2014 and has held it in 2 quarters since.
  • 1,860 funds tracked by Wall St. Rank held Pfizer as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.